Matches in Wikidata for { <http://www.wikidata.org/entity/Q92834382> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q92834382 description "article scientifique publié en 2019" @default.
- Q92834382 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92834382 description "scientific article published on 14 August 2019" @default.
- Q92834382 description "wetenschappelijk artikel" @default.
- Q92834382 description "наукова стаття, опублікована 14 серпня 2019" @default.
- Q92834382 description "գիտական հոդված հրատարակված 2019 թվականի օգոստոսի 14-ին" @default.
- Q92834382 name "A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma" @default.
- Q92834382 name "A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma" @default.
- Q92834382 type Item @default.
- Q92834382 label "A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma" @default.
- Q92834382 label "A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma" @default.
- Q92834382 prefLabel "A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma" @default.
- Q92834382 prefLabel "A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma" @default.
- Q92834382 P1433 Q92834382-CB8C3E1E-7807-44A3-A811-D2CC8FA9D1DD @default.
- Q92834382 P1476 Q92834382-74560387-AA5D-4AD7-8301-9CB010AF4CEB @default.
- Q92834382 P2093 Q92834382-384DED31-DAC9-4873-81B6-C6F097166512 @default.
- Q92834382 P2093 Q92834382-494F5682-E07C-461E-8BB9-A22A421015C8 @default.
- Q92834382 P2093 Q92834382-92F6E7F6-785F-412B-B7B9-7203784827F1 @default.
- Q92834382 P2093 Q92834382-A0BE2471-06B3-46E9-BE61-7209E4BF8EEF @default.
- Q92834382 P2093 Q92834382-A880EA2E-A5D7-4EF0-ABC5-73A9F5C66B68 @default.
- Q92834382 P2093 Q92834382-B6A2A612-240D-4F7D-8129-141BF4CFBF2D @default.
- Q92834382 P2093 Q92834382-C26A1738-3E66-45DB-8CB3-975A74BEFD43 @default.
- Q92834382 P2093 Q92834382-D1FC6619-15F1-4C81-9A69-4CB775B2223A @default.
- Q92834382 P2093 Q92834382-D207DE7E-B0F7-4825-8630-B9BA0B82FEBF @default.
- Q92834382 P2093 Q92834382-D849226E-361C-4D89-888B-B9E62068CB0E @default.
- Q92834382 P2093 Q92834382-EC3F698B-751C-4476-B72D-EE8D4B39B896 @default.
- Q92834382 P31 Q92834382-920063B1-DECA-45A0-9945-0FE459B05994 @default.
- Q92834382 P356 Q92834382-3AFB19F5-E485-4E97-8113-8B45C5B8D642 @default.
- Q92834382 P50 Q92834382-B548D181-E7C5-4552-9518-780C9842F5C3 @default.
- Q92834382 P577 Q92834382-572CBFED-CA89-4EF7-A48A-B9AEBC03BEE2 @default.
- Q92834382 P698 Q92834382-79C6EDC5-A025-4C7B-973A-138CBB4587A0 @default.
- Q92834382 P356 S10637-019-00844-X @default.
- Q92834382 P698 31444589 @default.
- Q92834382 P1433 Q2312231 @default.
- Q92834382 P1476 "A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma" @default.
- Q92834382 P2093 "Akito Yamaguchi" @default.
- Q92834382 P2093 "Amal Melhem-Bertrandt" @default.
- Q92834382 P2093 "Atsushi Takamoto" @default.
- Q92834382 P2093 "Elaina M Gartner" @default.
- Q92834382 P2093 "Motohide Uemura" @default.
- Q92834382 P2093 "Rio Akazawa" @default.
- Q92834382 P2093 "Takashi Inoue" @default.
- Q92834382 P2093 "Takeshi Kadokura" @default.
- Q92834382 P2093 "Tomokazu Kimura" @default.
- Q92834382 P2093 "Toshiki Tanikawa" @default.
- Q92834382 P2093 "Yoshihide Kawasaki" @default.
- Q92834382 P31 Q13442814 @default.
- Q92834382 P356 "10.1007/S10637-019-00844-X" @default.
- Q92834382 P50 Q88925476 @default.
- Q92834382 P577 "2019-08-14T00:00:00Z" @default.
- Q92834382 P698 "31444589" @default.